CTT Pharma Gives Uplisting Update
NYSE - LSE
| SCU | 0% | 12.72 | $ | |
| RBGPF | 0.08% | 75 | $ | |
| RIO | 0.58% | 60 | $ | |
| NGG | 1.14% | 72.65 | $ | |
| CMSC | 0.87% | 23.07 | $ | |
| GSK | 0.32% | 37.68 | $ | |
| BCC | -0.77% | 82.71 | $ | |
| AZN | 0.86% | 74.59 | $ | |
| SCS | 38.6% | 16.58 | $ | |
| BTI | 2.16% | 55.55 | $ | |
| RELX | 0.73% | 51.97 | $ | |
| CMSD | 1.18% | 23.63 | $ | |
| JRI | 0.76% | 13.2 | $ | |
| RYCEF | 2.07% | 14.5 | $ | |
| BCE | -1.12% | 23.31 | $ | |
| VOD | 0.72% | 11.04 | $ | |
| BP | 2.28% | 32.49 | $ |
CTT Pharma Gives Uplisting Update
TAMPA, FLORIDA / ACCESS Newswire / March 3, 2025 / CTT Pharmaceutical Holdings, Inc. (OTC PINK:CTTH) is expecting notification this week for uplisting status to the OTCQB. CTT will notify shareholders as more news becomes available.
CTT Pharma - 813-606-0060
SOURCE: CTT Pharmaceutical Holdings, Inc.
View the original press release on ACCESS Newswire
M.Meunier--JdCdC
